APA (7th ed.) Citation

Guan, Y., He, F., Wu, J., Zhao, L., Wang, X., Huang, L., . . . Zhao, X. (2018). A long‐acting pegylated recombinant human growth hormone (Jintrolong®) in healthy adult subjects: Two single‐dose trials evaluating safety, tolerability and pharmacokinetics. Journal of Clinical Pharmacy & Therapeutics, 43(5), 640. https://doi.org/10.1111/jcpt.12732

Chicago Style (17th ed.) Citation

Guan, Y., et al. "A Long‐acting Pegylated Recombinant Human Growth Hormone (Jintrolong®) in Healthy Adult Subjects: Two Single‐dose Trials Evaluating Safety, Tolerability and Pharmacokinetics." Journal of Clinical Pharmacy & Therapeutics 43, no. 5 (2018): 640. https://doi.org/10.1111/jcpt.12732.

MLA (9th ed.) Citation

Guan, Y., et al. "A Long‐acting Pegylated Recombinant Human Growth Hormone (Jintrolong®) in Healthy Adult Subjects: Two Single‐dose Trials Evaluating Safety, Tolerability and Pharmacokinetics." Journal of Clinical Pharmacy & Therapeutics, vol. 43, no. 5, 2018, p. 640, https://doi.org/10.1111/jcpt.12732.